Targeting antioxidant enzymes as a radiosensitizing strategy

Area of Science:

• Oncology
• Radiotherapy
• Cancer Biology

Background:

• Radiotherapy is a cornerstone cancer treatment that induces cancer cell death via reactive oxygen species (ROS).
• Cancer cells often develop resistance to radiotherapy by upregulating ROS-scavenging enzymes to manage intrinsic oxidative stress.
• Targeting these antioxidant defense mechanisms is a promising strategy to enhance radiotherapy efficacy.

Purpose of the Study:

• To review the critical role of ROS in mediating the response to radiotherapy.
• To examine the key systems regulating cellular redox homeostasis and their implications in radiotherapy.
• To identify potential radiosensitizers that function by inhibiting antioxidant enzymes.

Main Methods:

• Literature review of preclinical and clinical studies on ROS, redox homeostasis, and radiotherapy.
• Analysis of the mechanisms by which antioxidant enzymes contribute to radioresistance.
• Evaluation of pharmacological agents targeting antioxidant pathways as radiosensitizers.

Main Results:

• ROS are essential mediators of radiotherapy-induced cancer cell death.
• Dysregulation of redox homeostasis in cancer cells contributes significantly to radioresistance.
• Inhibition of ROS-scavenging enzymes can overcome radioresistance and improve treatment outcomes in preclinical models.

Conclusions:

• Understanding the redox biology of cancer is crucial for optimizing radiotherapy.
• Targeting antioxidant systems represents a viable strategy to enhance the effectiveness of cancer radiotherapy.
• Further clinical investigation of antioxidant inhibitors as radiosensitizers is warranted.